Written by Dr. Robert J Rowen on his official Facebook page – November 30th 2014
Dear Facebook Family,
You all have been devoted to our mission, and therefore you all should be the first to know the most fabulous news you will hear regarding the Ebola crisis. Dr. Robert Rowen and Dr. Howard Robins now openly announce to the world the first CONFIRMED case of Ebola which has been apparently cured with the Rowen-Robins Ebola protocol, which features the Robins method of DIV ozone administration.
If you’ve been reading the news, Dr. Komba Songu M’Briwa, a senior military physician in Sierra Leone, and one who had been with the now deceased Dr. Salia, contracted the disease, likely from embracing Dr. Salia when Salia’s first test came back negative. Dr. M’Briwa made international news on November 27, 2014 with the announcement that he contracted Ebola.…/af1fbd54-7627-11e4-a755-e32…
Dr. M’Briwa was presented with the offer of our ozone protocol, and signed the informed consent. This is the email Rowen got on November 27, 2014, from Dr. M. Jalloh, who became the managing physician of this case:
“Hello Dr. Rowen, This is Dr. M I Jalloh the guy who brought you the tennis shoes at Hastings [Ebola treatment center]. Hope you are fine.
I am not the one directly treating Dr. Songu M’brewa but I coordinate his treatment. He is presently stable with no diarrhea or vomiting. He is receiving the ozone (55 mls) twice a day. He is also receiving Advanced Cellular Silver (ACS 200), Vitamin C and Glutathione. The management is promising. They will probably run another Ebola test after ten doses of ozone to check if he is still positive and the viral load…Will keep you updated.”

Dr. Jalloh has indeed kept us updated. Today, November 30, only 3 days later, Dr. Jalloh has informed Dr. Rowen that Dr. M’Briwa promptly resolved his fever and had no further development of the usual Ebola symptoms of horror. In fact, he’s already been moved out of the Ebola sick unit into the “recovery” unit. Furthermore, a second test (for viral load) after treatment commenced was negative for Ebola, and a third test will be performed on Monday, December 1. You will be sure the naysayers will, like they often do when a confirmed cancer case “mysteriously” recovers at the hands of unconventional doctors, that they might say the same here. But it will be hard to do on this one. He had direct contact with Dr. Salia, he was personally treating Ebola, and he was housed in the Ebola treatment unit after testing positive. No one will be able to deny this one. And, he recovered exactly as we predicted would be the course of ozone-treated Ebola.
Now, here is an interesting twist to the story. You will remember our announcement of the first doctor we reported who jabbed himself with an infected needle? That was Dr. Sekou Kanneh, who was scared for his livelihood and life should he get a positive test, be quarantined, and then be denied ozone. Dr. Kanneh was the hands-on treating physician for Dr. M’Briwa, and was supervised in the program by Dr. Jalloh.
And finally, today, Dr. Rowen spontaneously got a delightful email from someone he didn’t recognize. It said, “Hi Dr . Its been a while since u left sierra Leone. How are u doing? We miss d ozone therapy.” When an email was sent inquiring as to the identity of the sender, this returned: “Am d head nurse nurse at Hastings ebola treatment centre. U gave me your email d last time u went there. Actually, we are taking ozone but my colleagues at other treatment centres around d country are not .
Sent from my BlackBerry® smartphone from Airtel Sierra Leone.
This appears to be the most promising advance in the Ebola crisis, and we are hopeful that everything we are being told from our sources is accurate. We are anxiously awaiting additional information regarding Dr. M’Briwa (and Dr. Kanneh). Folks, we wish to thank you for your support, your prayers and your love. We are bringing this case to the world now, and you can certainly help by getting it to news media, friends and family.
Sincerely, Robert Rowen, MD and Howard Robins, DPM

Drug-resistant superbug infections: 500% increase across U.S. hospitals

We’re in the post-antibiotic era.
Dr. Arjun Srinivasan, associate director at the Centers for Disease Control and Prevention

Drug-resistant superbug infections have reached near-epidemic levels across U.S. hospitals, with an alarming 500% increase now documented in a study just published in the August issue of Infection Control and Hospital Epidemiology (the journal of the Society for Healthcare Epidemiology of America).(1)


The CDC has admitted that we are now living in a “post-antibiotics era.” As Infection Control Today states, “Antibiotic resistance is no longer a prediction for the future. It is happening right now in every region of the world and has the potential to affect anyone.” (2)

Dr. Arjun Srinivasan, associate director at the Centers for Disease Control and Prevention, went even further in a PBS interview, stating: (3)

“We’ve reached the end of antibiotics, period… We’re here. We’re in the post-antibiotic era. There are patients for whom we have no therapy, and we are literally in a position of having a patient in a bed who has an infection, something that five years ago even we could have treated, but now we can’t.

Sources for this newsletter include:

Silver boosts the efficacy of antibiotics by 1000 times

New research shows that low doses of silver can massively boost the effect of antibiotics on bacteria, making them up to 1,000 times more sensitive to the drugs. The researchers hope their discovery will give new life to old antibiotics, including those to which microbes have become resistant.

A team lead by Jim Collins, a biomedical engineer at Boston University, showed that dissolved silver ions interfere with several cellular processes in bacteria, including disulfide-bond formation, iron homeostasis, and metabolism. These changes not only make the cell membrane more permeable, but also lead to increased production of reactive oxygen species, which can induce cell death via DNA damage.


silver_antibioticsThis work shows that silver can be used to enhance the action of existing antibiotics against Gram-negative bacteria, thus strengthening the antibiotic arsenal for fighting bacterial infections.” – Dr. Jim Collins, co-author of the study

When Collins and his colleagues supplemented antibiotics with a small amount of silver, both in vitro and in a mouse model of a urinary tract infection, the combination killed up to 1,000 times more bacteria than the antibiotics did on their own. In addition, the researchers showed that silver sensitizes Gram-negative bacteria to vancomycin, a large-molecule antibiotic that usually can’t breach the outer coating on the bacterial cell membranes.

Sources for this newsletter include: